Skip to main content

Table 1 Effect of diabetes mellitus on infarct size

From: Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning

Species

DM

 

Index ischemia

 

First author

Journal

 

type

duration

min

type

  

Infarct size enlargement

Dog

2

75 d

120

regional, vivo

Forrat

Cardiovasc Res 1993

Rat (SD)

1

8 d

25

regional, vivo

Marfella

Diabetologia 2002

Rat (SD)

1

8 d

25

regional, vivo

Di Filippo

Diabetes 2005

Rat (SD)

1

30 d

30

global, vitro

Thirunavukkarasu

Free Radic Biol Med 2007

Rat (Wistar)

1

2 w

30

regional, vivo

Xiao

J Pharmacol Exp Ther 2004

Rat (Zucker obese)

2

 

30

regional, vivo

Jordan

J Pharmacol Exp Ther 2003

Rat (Zucker obese)

2

(10-12 w old)

30

regional, vivo

Katakam

Am J Physiol 2007

Rat (Zucker diabetic fatty)

2

(10-12 w old)

30

regional, vivo

Yue

Diabetes 2005

Rat (Zucker diabetic fatty)

2

(12-16 w old)

30

regional, vivo

La Bonte

Am J Physiol 2008

Rat (OLETF)

2

(25-30 w old)

20

regional, vivo

Miki

Diabetes 2009

Rat (OLETF)

2

(25-30 w old)

20

regional, vivo

Hotta

Circ Res 2010

Mice

1

8 d

25

regional, vivo

Marfella

Diabetes 2004

Mice

1

4 w

60

regional, vivo

Liu

Diabetes 2005

Mice (ob/ob)

2

(8-10 w old)

30

regional, vivo

Bouhidel

Am J Physiol 2008

Mice (ob/ob)

2

(8-10 w old)

30

regional, vivo

Calvert

Diabetes 2008

Mice (ob/ob)

2

(10-12 w old)

30

regional, vivo

Zhu

J Cell Mol Med 2011

Mice (KK-Ay)

2

(6 w old)

40

regional, vivo

Honda

J Mol Cell Cardiol 2008

Infarct size reduction

Rabbit (NZ)

1

8 w

30

regional, vivo

Hadour

J Mol Cell Cardiol 1998

Rat (SD)

1

2 w

30

regional, vivo

Ma

N-S Arch Pharmacol 2006

Rat (Wistar)

2

11-12 m

30, 45

regional, vivo

Liu

Circulation 1993

Rat (Wistar)

1

1 w

30

regional, vivo

Ravingerová

Mol Cell Biochem 2003

Rat (Wistar)

1

4 w

30

regional, vivo

Xu

Exp Mol Pathol 2004

Rat (Wistar)

1

6 w

30

regional, vivo

Galagudza

Neurosci Behav Physiol 2007

Rat (Wistar)

2

10-12 w

30

global, vitro

Kravchuk

Exp Diabetes Res 2011

Rat (Wistar-Kyoto)

2

9 m

40

regional, vitro

Mozaffari

Hypertension 2003

Rat (Zucker diabetic fatty)

2

(16 w old)

50

regional, vitro

Kristiansen

Diabetologia 2004

Rat (Goto-Kakizaki)

2

(16 w old)

50

regional, vitro

Kristiansen

Diabetologia 2004

Rat (Goto-Kakizaki)

2

(16 w old)

45

regional, vitro

Kristiansen

Diabetologia 2011

No change in infarct size

Dog

1

3 w

60

regional, vivo

Kersten

Am J Physiol 2000

Dog

1

3 w

60

regional, vivo

Kersten

Am J Physiol 2001

Rabbit (NZ)

1

10-16 w

30

regional, vivo

Vogel

Circ Res 1988

Rabbit (NZ)

1

4-5 w

60

regional, vivo

Nieszner

Exp Clin Endocrinol Diabetes 2002

Rabbit (NZ white)

1

5-6 w

30

regional, vivo

Ebel

Pflügers Arch 2003

Rat (SD)

1

6 w

30

regional, vivo

Ma

N-S Arch Pharmacol 2006

Rat (SD)

1

2 w

30

regional, vivo

Gross

Diabetes 2007

Rat (SD)

1

4 w, 8 w

30

global, vitro

Shi-Ting

Biomed Pharmacother 2010

Rat (SD)

1

4-5 w

30

regional, vivo

Drenger

Anesthesiology 2011

Rat (SD)

1

4 w

30

global, vitro

Okazaki

J Mol Cell Cardiol 2011

Rat (Wistar)

1

8 w

30

regional, vitro

Joyeux

Cardiovasc Res 1999

Rat (Wistar)

1

8 w

30

regional, vivo

Ravingerová

Mol Cell Biochem 2003

Rat (Wistar)

1

20 w

30

regional, vivo

Xu

Exp Mol Pathol 2004

Rat (Wistar)

1

4 w

25

global, vitro

Ghaboura

Basic Res Cardiol 2011

Rat (Goto-Kakizaki)

2

 

35

regional, vitro

Tsang

Diabetes 2005

Rat (Goto-Kakizaki)

2

 

35

regional, vitro

Bhamra

Basic Res Cardiol 2008

Rat (Goto-Kakizaki)

2

(12 w old)

35

regional, vivo

Bulhak

Am J Physiol 2009

Rat (Goto-Kakizaki)

2

 

30

regional, vivo

Matsumoto

Cardiovasc Drug Ther 2009

Mice

1

2 w

30

global, vitro

Przyklenk

Antioxid Redox Signal 2011

Mice (ob/ob)

2

(12-14 w old)

30

global, vitro

Przyklenk

Antioxid Redox Signal 2011

  1. SD, Sprague–Dawley; NZ, New Zealand; OLETF, Otsuka Long-Evans-Tokushima fatty; d, days; w, weeks.